Censa Pharmaceuticals Overview

  • Founded
  • 2015
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 7
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $539M
Latest Deal Amount

Censa Pharmaceuticals General Information

Description

Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat orphan metabolic diseases with earlier stage programs targeting central nervous system diseases, disorders of neurotransmitter degradation and synthesis, enabling patients to recover debilitating diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Delivery
Parent Company
Primary Office
  • 65 William Street
  • Suite 200
  • Wellesley, MA 02481
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Censa Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 29-May-2020 $539M 00.000 00000 Completed Clinical Trials - Phase 3
3. Merger/Acquisition 05-Jan-2018 0000 0000 Cancelled Startup
2. Early Stage VC 21-Nov-2017 $1.5M $3.01M Completed Startup
1. Angel (individual) 19-Apr-2016 $1.51M $1.51M 000.00 Completed Startup
To view Censa Pharmaceuticals’s complete valuation and funding history, request access »

Censa Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 000,000 00.000000 00 00 00 00 00 0.000
To view Censa Pharmaceuticals’s complete cap table history, request access »

Censa Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of bio-medical therapeutics designed to treat (ultra) orphan CNS disorders. The company's therapeutics treat o
Biotechnology
Wellesley, MA
7 As of 2018
00.000
0000 0000-00-00
000000&0 00.000

00000000

do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostru
00000000000 0000000
San Rafael, CA
0000 As of 0000
00000
0000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Censa Pharmaceuticals Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
00000000 000000000 Formerly PE-Backed San Rafael, CA 0000 00000 0000 00000
To view Censa Pharmaceuticals’s complete competitors history, request access »

Censa Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Johnathan Reis MD President & Chief Executive Officer
Christopher Schelling Founder
To view Censa Pharmaceuticals’s complete executive team members history, request access »

Censa Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Censa Pharmaceuticals Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Arkin Holdings PE/Buyout Minority 000 0000 000000 0
InClin Other Minority 000 0000 000000 0
To view Censa Pharmaceuticals’s complete investors history, request access »